Viewing Study NCT03935334


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-01-08 @ 6:45 AM
Study NCT ID: NCT03935334
Status: COMPLETED
Last Update Posted: 2021-02-04
First Post: 2019-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors
Sponsor: AryoGen Pharmed Co.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module